Stock Events

Stock Events

Keros Therapeutics (KROS) Q4 2025 Earnings

5NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-1.36

0.3

1.96

3.62

Details

Expected EPS

-1.135089

Actual EPS

-0.18

Surprise EPS

0.96

Surprise Percent

+84.14%

Description

Keros Therapeutics (KROS) has reported earnings of -0.18 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.